Latest Insider Transactions at Armata Pharmaceuticals, Inc. (ARMP)
This section provides a real-time view of insider transactions for Armata Pharmaceuticals, Inc. (ARMP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Armata Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Armata Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2024
|
Deborah Birx Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+18.75%
|
-
|
|
Mar 14
2024
|
Richard Rychlik Corporate Controller and PFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Dec 21
2023
|
Deborah Birx Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+50.0%
|
-
|
|
Mar 31
2022
|
Innoviva, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
5,385,208
+24.76%
|
$26,926,040
$5.0 P/Share
|
|
Feb 09
2022
|
Innoviva, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
3,614,792
+24.77%
|
$18,073,960
$5.0 P/Share
|
|
Oct 29
2021
|
Innoviva, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
1,212,122
+14.13%
|
$3,636,366
$3.3 P/Share
|
|
Mar 17
2021
|
Innoviva, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
4,285,935
+41.05%
|
$12,857,805
$3.25 P/Share
|
|
Jan 26
2021
|
Innoviva, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
1,867,912
+50.0%
|
$5,603,736
$3.25 P/Share
|